News - General

Edmund (Ed) Vanderbeck joins XGen Pharmaceuticals DJB, Inc.

On May 4, 2020, Ed Vanderbeck joined XGen Pharmaceuticals DJB, Inc. as President, becoming only the third person to fill the position since the founding of Pharma-Tek almost 50 years ago.  Ed joins XGen DJB as a proven pharmaceutical industry leader having spent the...

The Release of Folic Acid Injection, USP

XGen Pharmaceuticals DJB, Inc. announced today it will begin marketing and distributing Folic Acid Injection, USP.  Folic Acid Injection, USP is a sterile non pyrogenic solution of sodium folate (prepared by the addition of sodium hydroxide to folic acid) in Water for...

The Relaunch of Ibuprofen Lysine

Big Flats NY – XGen Pharmaceuticals DJB Inc. announced today the relaunch of Ibuprofen Lysine injection.  Ibprofen Lysine injection is therapeutically equivalent to Recordati Rare Diseases’ NeoProfen® Injection.Ibuprofen Lysine Injection is indicated...

The Release of Dactinomycin for Injection, USP

Big Flats, NY., August 1st, 2019 – X-GEN Pharmaceuticals announced today the immediate availability in the United States of Dactinomycin for Injection, USP. Dactinomycin is an actinomycin indicated for the treatment of: • adult and pediatric patients with Wilms tumor,...

X-GEN Pharmaceuticals, Inc. Begins Supplying Magnesium Sulfate

Big Flats, NY, March 2, 2015 – X-GEN Pharmaceuticals announces availability of Magnesium Sulfate Injection, USP. Healthcare systems around the U.S are experiencing a shortage of Magnesium Sulfate, which is a critical component in Total Parenteral Nutrition...

X-GEN Pharmaceuticals, Inc. Begins Marketing Nystatin Topical

Big Flats, NY, September 26, 2014 – X-GEN Pharmaceuticals, Inc. announced today that it is re-launching Nystatin Topical Powder USP, a generic product AT rated to Mycostatin®. Nystatin Topical Powder is an antibiotic used to treat skin infections caused by a...